EGFR is involved in various cancers, including breast cancer, head and neck squamous cell carcinoma, colon cancer, ovarian cancer, pancreatic cancer, non-small-cell lung cancer (NSCLC), melanoma, and thyroid cancer. This evidence concerns the gene EGFR and non-small cell lung carcinoma.